Connective Tissue Peptides TRIZ Cases

See how partially hydrolyzed collagen compositions improve tensile strength and reduce bubble f

See how collagen-dextran polymer composition enables aligned fiber assembly through controlled

See how recombinant protein biopolymers with enzymatic crosslinking create biodegradable textil

See how collagen reacts with thermoplastic elastomers to create leather-like composites with en

See how genetically engineered yeast strains produce hydroxylated collagen with improved stabil

See how a collagen-dextran polymer composition forms aligned, shelf-stable collagen fibers with

See how spinning collagen into yarn before tanning creates uniform fiber organization, reducing

See how NDGA cross-linking with tensioned drying cycles produces collagen fibers reaching 180-3

Tension drying and solvent washing help NDGA cross-linked collagen fibers reach tendon-like strength and flexibility for bioprostheses.

NDGA-treated woven collagen implants restore tendon strength and flexibility, supporting early motion and native tissue ingrowth.

Braided NDGA-treated collagen fiber implants restore tendon and ligament strength while preserving mobility and supporting tissue ingrowth.

Repeated NDGA treatment, tension drying, and washing raise collagen fiber strength to tendon-like levels while preserving biocompatibility.

Braided collagen-derived prostheses improve tendon repair strength and flexibility while supporting tissue ingrowth and earlier mobility.

A multi-fiber collagen bioprosthesis restores tendon strength while supporting neo-tendon growth and reducing adhesion-limited mobility.

A multi-fiber collagen bioprosthesis restores tendon strength and stiffness while supporting neo-tendon growth and limiting scar formation.

A Titin-Telethonin fusion protein carrier stabilizes peptide drugs, limits degradation and rapid clearance, and extends in-vivo half-life.

Combining ordered and disordered polypeptide domains enables tunable phase-transition aggregates for cell scaffolds and drug delivery.

Hydrogen-bond-formable compounds and radical scavengers help radiosterilize low-water protein compositions while limiting degradation and denaturation.

Engineered HLA-DR/CII peptide complexes induce collagen II-specific immune tolerance to reduce arthritis inflammation without broad immunosuppression.

Edible biopolymer coatings form selective barriers that reduce water loss and slow ripening without plasticizers or taste changes.

5′-end guide RNA additions and spacer mismatches help edit one allele while reducing indels, off-target effects, and normal gene mutations.

Net-charged peptide sequences stay soluble at neutral pH, avoid tissue-damaging acidic formulations, and form shear-thinning hydrogels.

Serum detection of full-length CILP enables non-invasive monitoring of cardiac fibrosis progression and supports treatment adjustment.

Heat-activated ammonium persulfate cross-links recombinant resilin without enzyme residues, while polar solvents tune modulus and resilience.

Recombinant caviar polypeptides isolate the cosmetic-active proteins of caviar, enabling faster, cheaper, and ethical production for skincare use.

Engineered ActRIIB-Fc variants alter ligand binding to preserve activin and myostatin effects while reducing BMP9-related adverse effects.

A collagen-linked trimeric RSV F antigen preserves native-like conformation to induce neutralizing antibodies without enhancement risk.

Reversible Endo180 binding captures trimeric procollagen fusion proteins from complex samples, enabling rapid purification without disrupting native structure.

Small FN3 domains bind serum albumin to prolong therapeutic circulation while avoiding the size and immunogenicity drawbacks of HSA fusion.

Using water or pH-controlled aqueous coagulation liquids, this case shows safer protein fiber formation with lower fire risk, cost, and environmental load.

Targets disease-specific Th17 cells with autoimmune antigens and retinoic acid to curb inflammation without broad immunosuppression.

A linked EphA2-CD137 bicyclic peptide complex improves binding specificity and stability for anti-tumor activity with lower off-target effects.

A biodegradable RPE-photoreceptor bilayer improves retinal cell attachment and function by combining symbiotic cell support in one transplant.

Fusion of GDNF variants with Fc, albumin-binding, fibronectin, or albumin domains extends serum half-life while preserving metabolic and neurological efficacy.

A compact podocyte promoter preserves specific glomerular transgene expression while freeing AAV vector space for therapeutic genes.

Plasmalogen activates AMPK in fibroblasts to raise COL1A1, suppress MMP1, and promote collagen production for improved skin resilience.

An Fc-peptide hybrid selectively binds autoreactive lymphocytes and triggers ADCC, phagocytosis, and complement to reduce dermatitis side effects.

Strategic cysteine pairing adds disulfide bonds to a 10Fn3 VEGFR2 binder, improving thermostability and solubility without losing activity.

Podocyte-specific promoters and compact COL4A3/4/5 constructs help AAV vectors fit cargo limits while targeting kidney podocytes.